a public good project by the
Synthesis
Company
of California

© 2026

Anne Messer | doi.page

0 works0 citations0 h-index

Anne Messer

Publications by Year

Research Areas

Genetic Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research, Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neurological diseases and metabolism

Most-Cited Works

→ Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice(1999)415 cited
→ The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8(1999)318 cited
→ Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice(2000)291 cited
→ The maintenance and identification of mouse cerebellar granule cells in monolayer culture(1977)230 cited
→ Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease(2001)199 cited
→ Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody(2004)182 cited

→ MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice(2013)

173 cited

→ Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies(2005)135 cited

→ Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease(2010)122 cited

→ An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity(2007)121 cited